Purity Specifications, Storage and Distribution for Medications Development
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute on Drug Abuse under the National Institutes of Health is seeking capability statements from small businesses to serve as a centralized repository for chemical and biological compounds used in medication development. The contractor must possess in-house infrastructure to inventory, analyze, and store substances ranging from milligram to kilogram quantities, accommodating both non-GMP and GMP-grade materials sourced domestically and internationally. A critical requirement is the possession of a DEA Research Registration for Schedules II through V controlled substances, with the potential need to handle Schedule I compounds under the Controlled Substances Act of 1970. The facility must maintain rigorous purity specifications and secure distribution protocols to ensure compliance with federal regulations and the integrity of research materials. This notice is a sources sought announcement and not a solicitation for proposals or quotations; responses will not result in a contract award nor will the government compensate respondents for information provided. Interested parties must submit capability statements by August 15, 2026, to the point of contact Polina Klimenkova at polina.klimenkova@nih.gov. The North American Industry Classification System code is 541715, and performance will occur in Bethesda, Maryland. All submitted information should be clearly marked as proprietary if applicable, and no contractual obligation is implied by this announcement.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
TITLE: Purity Specifications, Storage and Distribution for Medications Development
This is a Sources Sought notice. THIS IS NOT A REQUEST FOR PROPOSALS, ABSTRACTS, OR QUOTATIONS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government's use. Any proprietary information should be so marked.
PROJECT REQUIREMENTS
The National Institute on Drug Abuse (NIDA) seeks capability statements from small businesses having the in-house capability to act as a centralized repository for compounds (i.e., chemical and biological) from domestic and international investigators, commercial sources, and pharmaceutical companies. Specifically, the project requires the following tasks:
The major goal of this project is to provide NIDA and other NIH Institutes with a holding site which has the capability to inventory, analyze and store compounds, prepared under both non-GMP (Good Manufacturing Practices) and GMP conditions, in amounts ranging from milligram quantities to several kilograms. In accordance with the Controlled Substances Act of 1970, DEA Research Registration for Schedules II to V and potentially Schedule I controlled substances will be required.
Please see the attachment for more details.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health
Same awarding agency
